Found 9 matching trials
Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
NARATIONALE: Drugs used in chemotherapy, such as doxorubicin, work in differe...
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma
NAThe purpose of this study is to determine if LC beads loaded with Doxorubic...
Location
University of Louisville
Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma
PHASE2The purpose of this study is to evaluate the effect of blocking the blood v...
Location
Memorial Sloan Kettering Cancer Center
Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With Doxorubicin
NAHepatocellular carcinoma (HCC) is the most common type of primary liver can...
Location
Multiple Locations
Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma
PHASE2The purpose of this study is to determine the feasibility and safety of usi...
Location
The Johns Hopkins Hospital
Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma
PHASE2This study will combine two therapies to treat patients with unresectable h...
Location
The Johns Hopkins Hospital
Survival Analysis: TACE vs. Combination Therapy in HCC
N/AThis retrospective observational study aimed to assess potential improvemen...
Location
First Affiliated Hospital, Medical College of Zhejiang University
LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed
PHASE2Advanced HCC represents a high unmet medical need with a poor prognosis and...
Location
UPMC Liver Cancer Center, Montefiore 7 South, 3459 Fifth Avenue
TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve
NATACE is frequently offered to patients with baseline hepatic dysfunction wi...
Location
University of California San Francisco